ARYS-0701 Site 3 — Beverly Hills, California

ARYS-0701 Site 3 is a clinical research site located in Beverly Hills, California, United States 90211.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

ARYS-0701 Site 3 has participated in 1 clinical trials.

Therapeutic areas: Herpes Zoster, Postherpetic Neuralgia.

Sponsors: aRigen Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Beverly Hills

Browse all research sites in California · View every site in Beverly Hills

• Cedars-Sinai Hospital
• University of Southern California
• Westside Prostate Cancer Center, University of Southern California
• Century City Doctors Hospital
• Retina-Vitreous Associates Medical Group
• Tower Cancer Research Foundation
• Research Site
• GSK Investigational Site
• Beverly Hills Cancer Center
• Cedars-Sinai Medical Center
• Novartis Investigative Site
• Pfizer Investigational Site

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ARYS-0701 Site 3?

ARYS-0701 Site 3 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ARYS-0701 Site 3 conducted?

ARYS-0701 Site 3 has 1 clinical trials on record. Their work covers Herpes Zoster, Postherpetic Neuralgia.

Is ARYS-0701 Site 3 accredited by Crixeo Clinical Trials?

ARYS-0701 Site 3 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ARYS-0701 Site 3?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.